Director/PDMR Shareholding

RNS Number : 6109J

GlaxoSmithKline PLC

01 July 2011

 



 Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons

I give below details of changes in the directors' interests in the Ordinary shares and American Depository Shares (ADSs) of GlaxoSmithKline plc.

On 30 June 2011, the Company's Non-Executive Directors were provisionally allocated awards over Ordinary shares at a price of £13.20 per Ordinary share and $42.43 per ADS under the share allocation arrangements for Non-Executive Directors for the period of service from 1 April 2011 to 30 June 2011:

Non Executive Director	Ordinary Shares	American Depository Shares (ADSs)
Sir Christopher Gent	2,556.818
Prof. Sir Roy Anderson	639.205
		488.684
Dr Stephanie Burns
Ms Stacey Cartwright	355.114
Mr Lawrence Culp		977.369
Sir Crispin Davis	2,367.424
Ms Judy Lewent		174.530
Sir Deryck Maughan		977.369
Mr James Murdoch	1,988.636
Dr Daniel Podolsky		942.463
Mr Tom de Swaan	875.947
Sir Robert Wilson	639.205

The Company and the Non-Executive Directors were informed of these allocations on 1 July 2011.

This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).

V A Whyte

Company Secretary

1 July 2011

 

END

 

 

RDSLFLFBFDFXBBV